PD-L1 expression levels have been identified as a predictor of response in some tumour types but is a relatively poor biomarker of response due to the fact it is not a static biomarker and does not offer binary discrimination of responsiveness [45, 46]. This evidence concerns the gene CD274 and neoplasm.